Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Cellect Biotechnology Ltd ADR
APOP
$
3.95
25%
Thu March 25th, 2021
11:58
Digest
The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut
Benzinga
